Celon Pharma works over cancer medicine

APA - Austria Presse Agentur
opublikowano: 12-10-2005, 18:39

Warsaw (Puls Biznesu) – Celon Pharma, a Polish pharmaceutical company, is working over five cancer medicines.

Warsaw (Puls Biznesu) – Celon Pharma, a Polish pharmaceutical company, is working over five cancer medicines.

- The first two medicines were implemented in the middle of 2004. Three are waiting to be registered, while there are researches conducted over five of them. One of those medicines is an innovative one, which may be a breakthrough in curing lung, pancreas, intestine and prostate cancer, Maciej Wieczorek, CP CEO said.

He added that the method proves effective. CP invests USD 1m (EUR 835,000) a year in research. Costs will rise.

For the time being, CP finances everything by itself. Sales from two medicines will let us pay for the first stage of clinical research. Then, we will start to look for investor. If the research is a success, we will try to find a partner, a big pharmaceutical company in two years’ time, CP CEO said.

(USD 1 = EUR 0.835)

© ℗
Rozpowszechnianie niniejszego artykułu możliwe jest tylko i wyłącznie zgodnie z postanowieniami „Regulaminu korzystania z artykułów prasowych” i po wcześniejszym uiszczeniu należności, zgodnie z cennikiem.

Podpis: APA - Austria Presse Agentur